PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress

Perfluorooctane sulfonate (PFOS) is a persistent perfluorinated compound associated with environmental exposure and biological accumulation. Because the kidney participates in PFOS elimination, renal tubular cells are an important model for examining its cellular toxicity. The reference study, Perfluorooctane sulfonate causes HK-2 cell injury through ferroptosis and endoplasmic reticulum stress pathways, investigates this problem by combining renal injury markers with measurements of iron-dependent lipid damage and unfolded-protein-response signaling.

Study Background and Research Question

PFOS has been used in applications that require chemical stability, low surface tension, and resistance to water and oil. Those same properties contribute to environmental persistence and make biological clearance difficult. The compound has been detected in human tissues and fluids, while experimental and epidemiological observations have raised concerns about kidney effects. The kidney is therefore not only a potential target organ but also a relevant site for investigating how persistent fluorinated compounds disturb cellular homeostasis.

The study focused on HK-2 cells, a human proximal tubular epithelial cell line. Its central question was whether PFOS-induced injury is associated with two mechanistically distinct but potentially interacting processes: ferroptosis and endoplasmic reticulum stress. Ferroptosis is an iron-dependent form of regulated cell death characterized by phospholipid peroxidation and impaired antioxidant protection. Endoplasmic reticulum stress develops when protein-folding capacity and cellular demand become unbalanced, activating the unfolded protein response through sensors and downstream transcriptional programs.

This question is important because a reduction in cell viability alone cannot identify the type of cell death involved. By measuring iron handling, lipid peroxidation, glutathione-dependent defense, and ER stress proteins in the same model, the authors sought to move from descriptive cytotoxicity toward pathway-level interpretation.

Key Innovation from the Reference Study

The principal contribution is the integrated analysis of ferroptosis-associated biochemical changes and ER stress signaling in PFOS-exposed renal epithelial cells. The reference study does not treat oxidative damage, iron accumulation, and protein-folding stress as isolated observations. Instead, it presents them as coordinated features of PFOS injury, supported by a panel that includes renal tubular damage, ferroptosis-related markers, and several branches of the endoplasmic reticulum stress pathway.

This design is useful for toxicology because ferroptosis and ER stress can produce overlapping manifestations of cellular dysfunction, including oxidative imbalance and loss of viability. A combined marker strategy helps distinguish a specific mechanistic pattern from nonspecific chemical injury. The work also provides a practical starting point for intervention studies: if ferroptosis inhibition or ER stress alleviation improves the phenotype, subsequent experiments can test whether one pathway is upstream of the other or whether both contribute independently.

Methods and Experimental Design Insights

HK-2 cells were exposed to PFOS, with a ferroptosis-focused comparator included in the design. According to the reference study, the principal treatment condition used 200 μM PFOS, while 1 μM ferrostatin-1 was used as the comparator treatment. These concentrations define an acute, mechanism-oriented cell culture experiment rather than a direct reconstruction of environmental serum or drinking-water exposure.

The investigators assessed cell viability and then examined several biochemical indicators. Malondialdehyde (MDA) was used to evaluate lipid peroxidation, reduced glutathione (GSH) represented an important antioxidant reserve, and intracellular total iron was measured to capture an essential ferroptosis-related variable. Glutathione peroxidase 4 (GPX4), a key suppressor of phospholipid peroxidation, was also evaluated. Together, these measurements address the balance between iron-driven oxidative damage and the cell's capacity to detoxify lipid hydroperoxides.

Renal injury and ER stress were examined at the protein-expression level. Kidney injury molecule-1 (KIM-1) served as a marker of proximal tubular damage. The ER stress panel included GRP78, ATF6, IRE1, and PERK, covering the major sensor and chaperone components commonly associated with the unfolded protein response. The strength of this design lies in its parallel readouts: viability indicates the outcome, MDA and iron indicate the damage environment, GSH and GPX4 indicate defense failure, and KIM-1 plus ER markers provide tissue-relevant and organelle-level context.

Protocol Parameters

• Cell model: Use human proximal tubular epithelial HK-2 cells when the experimental question concerns renal tubular responses to PFOS.
• PFOS exposure: The reference condition was 200 μM PFOS, as reported in the published study; this should be treated as a literature-specific acute exposure parameter, not as an environmental dose recommendation.
• Ferroptosis comparator: The study included 1 μM ferrostatin-1, according to the reference protocol, to support interpretation of ferroptosis-related injury.
• Outcome panel: Pair viability measurements with MDA, GSH, intracellular total iron, and GPX4 to evaluate ferroptosis-associated biochemical changes.
• ER stress and renal injury panel: Measure KIM-1 together with GRP78, ATF6, IRE1, and PERK to connect tubular damage with the endoplasmic reticulum stress pathway.

Core Findings and Why They Matter

PFOS exposure significantly increased KIM-1 expression in HK-2 cells. This finding supports the interpretation that the treatment produced a renal tubular injury phenotype rather than merely altering an isolated metabolic endpoint. In a kidney toxicology model, KIM-1 is particularly informative because proximal tubular epithelial cells are vulnerable to chemical and oxidative stress.

The ferroptosis-associated profile was characterized by increased MDA and intracellular total iron together with decreased GSH and GPX4. Elevated MDA is consistent with enhanced lipid peroxidation, while increased intracellular iron supplies a catalytic environment that can intensify oxidative damage to membrane phospholipids. The reduction in GSH weakens cellular redox buffering, and lower GPX4 further limits the removal of lipid hydroperoxides. Considered together, these results are more compatible with ferroptosis-related injury than with a nonspecific increase in reactive oxygen species alone.

The study also found increased expression of GRP78, ATF6, IRE1, and PERK after PFOS treatment. GRP78 is associated with the accumulation of unfolded or misfolded proteins, whereas ATF6, IRE1, and PERK represent major ER stress sensors and signaling branches. Their coordinated elevation indicates activation of the unfolded protein response. Importantly, the findings do not establish that ER stress is solely upstream of ferroptosis. They do show that both processes are active in the same PFOS-injured renal cell model, creating a biologically plausible basis for studying pathway interaction.

The ferrostatin-1 arm adds an intervention-oriented dimension to the experiment. However, the condensed findings available for this article do not provide a quantitative description of how strongly ferrostatin-1 rescued viability or normalized each marker. That distinction matters: the biomarker pattern supports ferroptosis involvement, while a fully causal claim would require detailed rescue data, time-course analysis, and ideally complementary genetic or pharmacological perturbations.

Interpreting the combined mechanism

One possible interpretation is that PFOS-associated redox disruption and iron accumulation increase membrane lipid damage while cellular protein-folding capacity is simultaneously challenged. ER stress may amplify oxidative imbalance through altered metabolism and stress signaling, whereas ferroptotic damage may further compromise organelle function. The reference study establishes the coexistence of these signatures; it does not resolve their precise order. That unresolved relationship is scientifically valuable because it identifies a testable mechanistic gap rather than presenting correlation as definitive pathway hierarchy.

Comparison with Existing Internal Articles

The internal article PFOS Induces Ferroptosis and ER Stress in Kidney HK-2 Cells addresses the same reference findings and is useful as a concise mechanistic overview. The present analysis places greater emphasis on experimental interpretation: why the MDA, iron, GSH, and GPX4 combination is informative, how KIM-1 anchors the work in renal injury, and why the ER stress markers should not be interpreted as proof of a one-way causal sequence. Together, the two resources connect the paper's central conclusion with the reasoning needed to design follow-up toxicology experiments.

Limitations and Transferability

Several limitations affect how broadly these findings can be generalized. First, HK-2 cells are an in vitro model and cannot reproduce renal blood flow, filtration, tubular transport, immune-cell interactions, or whole-organism PFOS distribution. Results in this cell line should therefore be viewed as mechanistic evidence rather than a direct estimate of human kidney risk.

Second, the reported PFOS concentration is substantially higher than many environmental measurements. High-concentration exposure can be useful for identifying cellular pathways, but it may exaggerate responses or activate stress programs that are less prominent during chronic low-level exposure. Concentration-response studies, repeated or extended exposure designs, and measurements of intracellular PFOS would help determine whether the same mechanism operates across more realistic exposure ranges.

Third, the marker panel is supportive but not exhaustive. Increased iron and MDA with reduced GSH and GPX4 are consistent with ferroptosis, yet they should ideally be interpreted alongside additional lipid-species measurements, membrane damage analyses, and multiple ferroptosis-directed controls. Similarly, increased GRP78, ATF6, IRE1, and PERK indicates ER stress signaling but does not by itself demonstrate whether the unfolded protein response is adaptive, maladaptive, or temporally upstream of cell death.

Finally, the study provides a pathway framework rather than a complete therapeutic model. Future work should clarify temporal relationships between ER stress and ferroptosis, examine whether interventions rescue KIM-1 and viability in parallel, and test the observations in primary renal cells or animal models. These extensions would improve transferability without changing the reference study's central contribution: PFOS can injure renal tubular cells while activating both iron-dependent lipid damage and ER stress responses.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

Using a chemical chaperone to probe ER stress alleviation could help test whether the ER response is functionally involved in PFOS-related ferroptotic injury. This is a logical bridge from environmental kidney toxicology to mechanistic ER stress research, but it remains a proposed follow-up application rather than an intervention demonstrated by the reference paper. Any conclusion would require matched controls, pathway-specific rescue measurements, and confirmation that changes in viability are not caused by unrelated effects of the test compound.

For such experiments, researchers can use 4-Phenylbutyric acid (4-PBA, SKU C6831) as a chemical chaperone for ER stress workflows, including studies that examine the endoplasmic reticulum stress pathway alongside apoptosis research or autophagic cell death modulation. APExBIO product information reports a purity of at least 98%, solubility at or above 31 mg/mL in DMSO and 29.5 mg/mL in ethanol, water insolubility, and recommended storage at −20°C. These formulation details should be considered during vehicle controls, concentration selection, and short-term solution preparation.